* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Leukaemia Section t(9;21)(q34;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Essential gene wikipedia , lookup
Y chromosome wikipedia , lookup
Gene expression programming wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Neocentromere wikipedia , lookup
Quantitative trait locus wikipedia , lookup
X-inactivation wikipedia , lookup
Oncogenomics wikipedia , lookup
Genome evolution wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Microevolution wikipedia , lookup
Public health genomics wikipedia , lookup
Ridge (biology) wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Genomic imprinting wikipedia , lookup
Minimal genome wikipedia , lookup
Gene expression profiling wikipedia , lookup
Designer baby wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Leukaemia Section Short Communication t(9;21)(q34;q22) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France (JLH) Published in Atlas Database: February 2008 Online updated version: http://AtlasGeneticsOncology.org/Anomalies/t0921q34q22ID1483.html DOI: 10.4267/2042/44413 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology factor, critical regulator of hematopoietic-cell development, involved in many de novo and treatment related leukaemias. The exons 1-4 of RUNX1 were fused to repetitive sequences from chromosome 9, adding 70 amino acids to RUNX1 exon 4 encoding sequences, resulting in a truncated RUNX1. The t(9;21)/RUNX1 involvement may be responsible for the transformation of the EMS. Clinics and pathology Disease Acute myeloid leukaemia (AML) Epidemiology Only one case to date. Clinics References The patient was a 75 year old male patient with a myeloproliferative syndrome (MPS) in transfor-mation to AML. The MPS was a 8p11 myelo-proliferative syndrome (EMS). Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T, Mitelman F, Johansson B. Fusion of the BCR and the fibroblast growth factor receptor1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosomes Cancer. 2001 Dec;32(4):302-10 Cytogenetics Cytogenetics morphological Agerstam H, Lilljebjörn H, Lassen C, Swedin A, Richter J, Vandenberghe P, Johansson B, Fioretos T. Fusion genemediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer. 2007 Jul;46(7):63543 The karyotype also comprised a t(8;22)(p11;q11) with BCR/ FGFR fusion, responsible for the EMS. Genes involved and proteins Note RUNX1 was involved in the translocation. RUNX1, also called AML1 or CBFA2, is a transcription Atlas Genet Cytogenet Oncol Haematol. 2009; 13(2) This article should be referenced as such: Huret JL. t(9;21)(q34;q22). Atlas Genet Cytogenet Oncol Haematol. 2009; 13(2):141. 141